{"entities":{"Q85105":{"pageid":75490,"ns":120,"title":"Item:Q85105","lastrevid":462338,"modified":"2026-08-15T10:28:01Z","type":"item","id":"Q85105","labels":{"mul":{"language":"mul","value":"ID_1121924544"},"pt-br":{"language":"pt-br","value":"Neuropatia vascul\u00edtica ou associada a vasculite"},"en":{"language":"en","value":"Vasculitis or vasculitic neuropathy"}},"descriptions":{"pt-br":{"language":"pt-br","value":"A neuropatia vascul\u00edtica tem in\u00edcio agudo ou subagudo, ocorre mais frequentemente com a idade e \u00e9 caracterizada por uma neuropatia multifocal frequentemente dolorosa (mononeurite m\u00faltipla). H\u00e1 prefer\u00eancia pelos nervos fibular, tibial posterior, ulnar, mediano e radial. Tamb\u00e9m s\u00e3o as plexopatias vascul\u00edticas mais frequentes no plexo lombossacral do que no plexo braquial. A neuropatia vascul\u00edtica costuma aparecer em conjunto com caracter\u00edsticas sist\u00eamicas como perda de peso e mal-estar. A vasculite \u00e9 caracterizada por inflama\u00e7\u00e3o epineural, frequentemente necrose e inflama\u00e7\u00e3o da parede do vaso, seguida por perda axonal e les\u00f5es fasciculares irregulares. O tratamento com corticosteroides, \u00e0s vezes em combina\u00e7\u00e3o com outros imunossupressores, \u00e9 necess\u00e1rio para controlar o processo inflamat\u00f3rio e prevenir danos nervosos isqu\u00eamicos adicionais."},"en":{"language":"en","value":"Vasculitic neuropathy has an acute or subacute onset, occurs more frequently with age and is characterised by an often painful multifocal neuropathy (mononeuritis multiplex). There is a preference for peroneal, posterior tibial, ulnar, median and radial nerves. Also are vasculitic plexopathies more frequent in the lumbosacral than in the brachial plexus. Vasculitic neuropathy appears often in conjunction with systemic features as weight loss and malaise. The vasculitis is characterised by epineurial inflammation, often vessel wall necrosis and inflammation, followed by axonal loss, and patchy fascicular lesions. Treatment with corticosteroids, sometimes in combination with other immunosuppressants, is required to control the inflammatory process and prevent further ischemic nerve damage."}},"aliases":{},"claims":{"P68":[{"mainsnak":{"snaktype":"value","property":"P68","hash":"6572d8646a242d489a84b2ee7221f7cd938a71f9","datavalue":{"value":"https://id.who.int/icd/entity/1121924544","type":"string"},"datatype":"url"},"type":"statement","id":"Q85105$DF491EBE-F73A-4288-BA81-AF44A9B8C55A","rank":"normal"}],"P67":[{"mainsnak":{"snaktype":"value","property":"P67","hash":"944191d4e5ffbfccf6b4420ca3961bd10b5e91a5","datavalue":{"value":"CID11:ID_1121924544","type":"string"},"datatype":"string"},"type":"statement","id":"Q85105$14040952-6BC4-4D11-8F14-F62A00E19637","rank":"normal"}],"P70":[{"mainsnak":{"snaktype":"value","property":"P70","hash":"bd114ead0408ba57140207c55c0a2c1d79024f88","datavalue":{"value":"dki-india-ID_1121924544","type":"string"},"datatype":"string"},"type":"statement","id":"Q85105$755DB477-DA6C-41DF-8B85-366351BBE53E","rank":"normal"}],"P86":[{"mainsnak":{"snaktype":"value","property":"P86","hash":"a96031634b9f5dafddaf781bbba3adea6bb64ef4","datavalue":{"value":"Conclu\u00eddo","type":"string"},"datatype":"string"},"type":"statement","id":"Q85105$73CE0E9E-992D-4EDC-A88E-4705E2ABB0AD","rank":"normal"}],"P78":[{"mainsnak":{"snaktype":"value","property":"P78","hash":"5f9b5be68b7400da549761cf15abfdbc4d1e075b","datavalue":{"value":"https://pauloleads.com.br/cases-publicos/","type":"string"},"datatype":"url"},"type":"statement","id":"Q85105$5C93ACA9-E76B-4E74-A124-35E683DA91FA","rank":"normal"}],"P80":[{"mainsnak":{"snaktype":"value","property":"P80","hash":"92b8222fcbb75718504f915073a3f43bd4003d18","datavalue":{"value":{"time":"+2026-08-13T00:00:00Z","timezone":0,"before":0,"after":0,"precision":11,"calendarmodel":"http://www.wikidata.org/entity/Q1985727"},"type":"time"},"datatype":"time"},"type":"statement","id":"Q85105$CBA57438-6BC0-460A-AFF6-6AD6ABAC1BD5","rank":"normal"}]},"sitelinks":{}}}}